Alvotech (ALVO)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Alvotech Stock (ALVO) Company Profile

Healthcare (1064)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ALVO's Discussions on Twitter

Compare ALVO vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALVO Alvotech	5.45	2.05B	563.46M	27.92M	-146.33M	0.0964
TAK Takeda Pharmaceutical Co Adr	17.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.53	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.80	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	69.69	29.36B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.70	20.39B	3.17B	1.29B	1.01B	27.09

Alvotech Stock (ALVO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-11-04	Herabstufung	Deutsche Bank	Buy → Hold
2025-10-14	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2025-09-23	Hochstufung	Deutsche Bank	Hold → Buy
2025-02-14	Eingeleitet	UBS	Buy
2024-01-29	Hochstufung	Barclays	Equal Weight → Overweight
2023-10-20	Hochstufung	Citigroup	Sell → Neutral
2023-09-21	Eingeleitet	Barclays	Equal Weight
2022-09-07	Eingeleitet	Morgan Stanley	Equal-Weight
2022-09-06	Herabstufung	Citigroup	Buy → Sell
2022-07-26	Eingeleitet	Citigroup	Buy

Alle ansehen

Alvotech Aktie (ALVO) Neueste Nachrichten

Finanzdaten der Alvotech-Aktie (ALVO)

Alvotech (ALVO)

Alvotech Stock (ALVO) Company Profile

Compare ALVO vs TAK, TEVA, HLN, ZTS, UTHR

Alvotech Stock (ALVO) Upgrades & Downgrades

Alvotech Aktie (ALVO) Neueste Nachrichten

Alvotech Cash Flow – HAN:Z45 - TradingView

Average basic shares outstanding of Alvotech – HAN:Z45 - TradingView

Alvotech stock draws Barclays upgrade ahead of FDA decisions - AD HOC NEWS

ALVO Stock Price, Quote & Chart - ChartMill

Alvotech (NASDAQ:ALVO) Shares Up 3.5%Here's What Happened - MarketBeat

Alvotech (ALVO) Jumped, But What Is Driving Attention Now? - simplywall.st

Alvotech (NASDAQ:ALVO) Trading Up 7.2%Should You Buy? - MarketBeat

Can Alvotech (NASDAQ:ALVO) Change Its Healthcare Story? - Kalkine Media

Alvotech (NASDAQ:ALVO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Positive Report for Alvotech (ALVO) from Barclays - theglobeandmail.com

Why This Biotech Stock Just Got a Rare Double Upgrade - Barron's

ALVO Stock Jumps On Double Upgrade — Why Barclays Sees A 59% Upside - TradingView

Alvotech Jumps Most Since December After Barclays Doubles Price Target to $8 - finance.biggo.com

Alvotech Shares Rise After Double Upgrade From Barclays - marketscreener.com

Alvotech stock surges on Barclays upgrade to Overweight - Investing.com

Alvotech stock surges on Barclays upgrade to Overweight By Investing.com - Investing.com South Africa

Alvotech (NASDAQ:ALVO) Shares Gap UpHere's What Happened - MarketBeat

Alvotech stock gains on double upgrade at Barclays (ALVO:NASDAQ) - Seeking Alpha

LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday - benzinga.com

Alvotech Price Target Raised to $8.00/Share From $4.00 by Barclays - Moomoo

Alvotech Shares Rise 5.6% After Barclays Upgrades Rating and Doubles Price Target - Yahoo Finance

Why is Alvotech stock rallying 5% today? - Investing.com

Barclays Upgrades Alvotech(ALVO.US) to Buy Rating, Raises Target Price to $8 - Moomoo

Barclays Upgrades Alvotech (NASDAQ: ALVO) Stock As FDA Inspection Clears Path To U.S. Approvals - foreignpolicyjournal.com

Barclays upgrades Alvotech stock rating on FDA approval outlook - Investing.com

Certain Stock Options of Alvotech are subject to a Lock-Up Agreement Ending on 14-SEP-2026. - marketscreener.com

How FDA Filing Acceptance Will Impact Alvotech (ALVO) Investors - simplywall.st

What Is Putting Alvotech Stock in Focus? (NASDAQ:ALVO) - Kalkine Media

Citadel Advisors LLC Makes New $6.38 Million Investment in Alvotech $ALVO - MarketBeat

Understanding the Setup: (ALVO) and Scalable Risk - Stock Traders Daily

Alvotech (ALVO) Is Up 7.5% After FDA Accepts Review Of Key Entyvio Biosimilar AVT80 - simplywall.st

Alvotech and Lotus Enter Agreement for Durvalumab and Emicizumab Biosimilars - marketscreener.com

Takeda Files Second Vedolizumab Biosimilar BPCIA Action with Alvotech in the Firing Line - Pearce IP

Alvotech’s Subcutaneous Biosimilar Vedolizumab BLA Accepted for Review by FDA - Pearce IP

Alvotech (NASDAQ:ALVO) Shares Up 5.4%Here's What Happened - MarketBeat

FDA to review Alvotech (Nasdaq: ALVO) subcutaneous Entyvio biosimilar - stocktitan.net

Alvotech Says FDA Accepted Biologics License Application for AVT80 - marketscreener.com

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations - Yahoo Finance

Update: Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80 - Yahoo Finance

Alvotech (ALVO) Is Up 11.7% After Lotus Biosimilar Licensing Deal and 2026 Guidance Update – Has The Bull Case Changed? - simplywall.st

Why Alvotech (ALVO) Is Up 11.7% After Expanding Biosimilar Deal With Lotus Pharmaceutical - Yahoo Finance

Alvotech (ALVO) Stock Still Trades At A Discount After A 57% Rally - simplywall.st

Alvotech to present at upcoming investor conferences in September - Yahoo Finance

Alvotech (ALVO) On FDA Clearance And Lotus Deal As Undervalued Narrative Gains Ground - simplywall.st

Alvotech's Q4 Approval, Launch Timelines Remain Intact, UBS Says - Yahoo Finance

Why Alvotech (ALVO) Is Up 9.2% After $150 Million Lotus Biosimilar Deal And 2026 Update - Sahm

ALVOTECH ($ALVO) Releases Q2 2026 Earnings - Moomoo

Alvotech licenses durvalumab and emicizumab biosimilar candidates to Lotus in ~$150M deal - Dealroom

Alvotech Targets Three U.S. Biosimilar Decisions In Q4 After FDA Manufacturing Inspection Closes - Pulse 2.0

Teleconferência de Resultados do 2T26 da Alvotech (ALVO): Guidance Reafirmado - TradingKey

Alvotech (NASDAQ:ALVO) Builds Momentum Around Biosimilar Expansion - Kalkine Media

Finanzdaten der Alvotech-Aktie (ALVO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie ALVO